LUCENT
Matthew Goodman serves as the CEO and Medical Director of LUCENT biopharma, a medical consultancy firm aiding pharmaceutical and biotech companies in market entry for new medicines. With extensive experience in medical affairs, clinical development, and leadership roles across various organizations, Goodman has shaped innovative medical models within the biopharma industry. Previous positions include Medical Director at XYLEM Medical and CEO at LUX Health Technologies, where groundbreaking work was done in healthcare AI and patient care technologies. Additionally, Goodman serves as a Guest Lecturer and Industry Mentor at UCL Global Business School for Health, guiding projects in biopharma and health-tech, and has held numerous senior medical roles in major pharmaceutical companies. Educational qualifications include degrees in Pharmaceutical Medicine and Medicine, underscoring a solid foundation in medical expertise.
This person is not in any teams
LUCENT
At LUCENT we believe that there’s no greater undertaking than working to improve the health and wellbeing of patients. We support life science companies across the world, helping to successfully bring medical innovations to patients faster. We exclusively focus on Medical, reinforcing our expertise with first-hand experience of the challenges you face, and excelling in five domains: 1️⃣ Clinical Development 2️⃣ Medical Affairs 3️⃣ Field Medical 4️⃣ Medical Omnichannel 5️⃣ Medical Operations Contact us today to schedule a meeting and join world-class biopharma leaders in leveraging our Medical expertise.